172 related articles for article (PubMed ID: 16600446)
1. Evaluation of a novel Vi conjugate vaccine in a murine model of salmonellosis.
Hale C; Bowe F; Pickard D; Clare S; Haeuw JF; Powers U; Menager N; Mastroeni P; Dougan G
Vaccine; 2006 May; 24(20):4312-20. PubMed ID: 16600446
[TBL] [Abstract][Full Text] [Related]
2. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
[TBL] [Abstract][Full Text] [Related]
3. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.
Svenson SB; Nurminen M; Lindberg AA
Infect Immun; 1979 Sep; 25(3):863-72. PubMed ID: 387597
[TBL] [Abstract][Full Text] [Related]
4. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
5. Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.
Watson DC; Robbins JB; Szu SC
Infect Immun; 1992 Nov; 60(11):4679-86. PubMed ID: 1383154
[TBL] [Abstract][Full Text] [Related]
6. Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice.
Sagi SS; Paliwal P; Bansal A; Mishra C; Khan N; Mustoori SR; Ilavazhagan G; Sawhney RC; Banerjee PK
Vaccine; 2006 Nov; 24(49-50):7135-41. PubMed ID: 16887241
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi.
Rondini S; Micoli F; Lanzilao L; Hale C; Saul AJ; Martin LB
Clin Vaccine Immunol; 2011 Mar; 18(3):460-8. PubMed ID: 21248155
[TBL] [Abstract][Full Text] [Related]
8. Conjugation of tetanus toxoid with Salmonella typhimurium PTCC 1735 O-specific polysaccharide and its effects on production of opsonizing antibodies in a mouse model.
Jazani NH; Worobec E; Shahabi S; Nejad GB
Can J Microbiol; 2005 Apr; 51(4):319-24. PubMed ID: 15980894
[TBL] [Abstract][Full Text] [Related]
9. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
[TBL] [Abstract][Full Text] [Related]
10. Development and duration of protection against salmonellosis in mice and sheep immunised with live aromatic-dependent Salmonella typhimurium.
Mukkur TK; Walker KH
Res Vet Sci; 1992 Mar; 52(2):147-53. PubMed ID: 1533950
[TBL] [Abstract][Full Text] [Related]
11. Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain.
Lindberg AA; Segall T; Weintraub A; Stocker BA
Infect Immun; 1993 Apr; 61(4):1211-21. PubMed ID: 7681041
[TBL] [Abstract][Full Text] [Related]
12. Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.
Simon R; Levine MM
Hum Vaccin Immunother; 2012 Apr; 8(4):494-8. PubMed ID: 22370510
[TBL] [Abstract][Full Text] [Related]
13. Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.
Szu SC; Taylor DN; Trofa AC; Clements JD; Shiloach J; Sadoff JC; Bryla DA; Robbins JB
Infect Immun; 1994 Oct; 62(10):4440-4. PubMed ID: 7927707
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and protective efficacy against
Schuster O; Sears KT; Ramachandran G; Fuche FJ; Curtis B; Tennant SM; Simon R
Hum Vaccin Immunother; 2019; 15(6):1436-1444. PubMed ID: 29873578
[TBL] [Abstract][Full Text] [Related]
15. Protective efficacy and immunogenicity of Vi-porin conjugate against Salmonella typhi.
Singh M; Ganguly NK; Kumar L; Vohra H
Microbiol Immunol; 1999; 43(6):535-42. PubMed ID: 10480549
[TBL] [Abstract][Full Text] [Related]
16. Immune responses in calves immunised orally or subcutaneously with a live Salmonella typhimurium aro vaccine.
Villarreal-Ramos B; Manser J; Collins RA; Dougan G; Chatfield SN; Howard CJ
Vaccine; 1998 Jan; 16(1):45-54. PubMed ID: 9607008
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
[TBL] [Abstract][Full Text] [Related]
18. Salmonella typhimurium infection in calves: cell-mediated and humoral immune reactions before and after challenge with live virulent bacteria in calves given live or inactivated vaccines.
Lindberg AA; Robertsson JA
Infect Immun; 1983 Aug; 41(2):751-7. PubMed ID: 6347896
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Lon-deficient Salmonella strain as an oral vaccine candidate.
Kodama C; Eguchi M; Sekiya Y; Yamamoto T; Kikuchi Y; Matsui H
Microbiol Immunol; 2005; 49(12):1035-45. PubMed ID: 16365528
[TBL] [Abstract][Full Text] [Related]
20. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
Chen H; Schifferli DM
Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
